Guangzhou Baiy reported CNY2.26B in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Aspen Pharmacare ZAR 3.76B 1.04B Dec/2025
Cipla INR 6.14B 3.63B Mar/2026
Dr.Reddys Laboratories INR 888M 13.05B Mar/2026
Jiangsu Hengrui CNY 2.56B 302M Mar/2026
Kalbe Farma IDR 851.77B 208.4B Sep/2025
Richter Gedeon HUF 62.32B 1.26B Mar/2026
Sh Fosun Pharma CNY 817.9M 46.25M Mar/2026
Sh Pharmaceutical CNY 1.88B 283.52M Dec/2025
Sun Pharmaceuticals INR 40.62B 6.95B Dec/2025
Teva Pharmaceutical Industries USD 758M 271M Mar/2026